Patents Assigned to NIRRIN TECHNOLOGIES, INC.
-
Patent number: 12663378Abstract: A device for monitoring a bioreactor is designed for in-situ analysis, e.g., by NIR. The device is configured for maintaining a sample detection region in the reactor medium and can include two or more components, at least one of which is fabricated additively. In an example, a light beam propagates along a free space optical path, passes through a thin 3D printed layer and traverses the sample detection region, where it becomes modulated or modified by interactions with analytes present in the bioreactor. The transmitted light reaches and passes through another thin 3D printed layer and is detected by a photodetector, internal to the device. The electrical signal from the photodetector can be directed to an analyzer via electrical connections. The device or a component thereof can be designed for single use applications.Type: GrantFiled: March 2, 2022Date of Patent: June 23, 2026Assignee: NIRRIN TECHNOLOGIES, INC.Inventors: Bryan A. Hassell, David P. Marchessault
-
Patent number: 12546795Abstract: A foam sensor device is used for monitoring foam within a vessel. The sensor (e.g. accelerometer) is encapsulated inside a water-tight, sterilizable, shell, which floats on a liquid contained. In one example, the foam sensor device includes an accelerometer for detecting and measuring rotation and movement of the foam sensor device and generates movement data based on the detected movement. During a learning or calibration process, sensor data (e.g., movement data) from the foam sensor device is analyzed and classified using machine learning and/or signal processing methods to extract features indicative of different possible foam statuses, including varying levels of foam, or no foam and generate models for the different statuses. During normal operation, the foam sensor device transmits sensor data to an analyzer containing the pre-calibrated models, which determines whether there is foam or not. Based on the foam status, a pump controller adds anti-foam solution.Type: GrantFiled: February 16, 2022Date of Patent: February 10, 2026Assignee: Nirrin Technologies, Inc.Inventor: Bryan A. Hassell
-
Patent number: 12492994Abstract: A method for studying cell viability and protein aggregation involves establishing a Fabry Perot etalon signal within an optical spectroscopic feature, e.g., in the near infrared region. Protein aggregation and cell viability can be reflected by changes observed in the magnitude of the Fourier Transform peaks observed in the frequency or space domain associated with the contrast of the etalon. In short, the presence of viable cells and protein aggregates can degrade the etalon contrast of an etalon window. In some cases, the concentration of cells and monomeric protein can be measured as well.Type: GrantFiled: June 5, 2024Date of Patent: December 9, 2025Assignee: Nirrin Technologies, Inc.Inventors: Bryan A. Hassell, Walid A. Atia, David P. Marchessault
-
Patent number: 12222279Abstract: A flowcell device, including a flow pathway and an optical subassembly, has a flowcell body that is continuous with a sample being analyzed and a temperature controlled surface. The flowcell body can be disposed between a thermalplate, actively regulated by a thermoelectric cooler, and an insulating member. The flowcell device can be employed in a bioreactor monitoring system.Type: GrantFiled: January 24, 2020Date of Patent: February 11, 2025Assignee: Nirrin Technologies, Inc.Inventors: Bryan A. Hassell, Aaron Delahanty
-
Patent number: 12031908Abstract: A method for studying cell viability and protein aggregation involves establishing a Fabry Perot etalon signal within an optical spectroscopic feature, e.g., in the near infrared region. Protein aggregation and cell viability can be reflected by changes observed in the magnitude of the Fourier Transform peaks observed in the frequency or space domain associated with the contrast of the etalon. In short, the presence of viable cells and protein aggregates can degrade the etalon contrast of an etalon window. In some cases, the concentration of cells and monomeric protein can be measured as well.Type: GrantFiled: November 11, 2020Date of Patent: July 9, 2024Assignee: Nirrin Technologies, Inc.Inventors: Bryan A. Hassell, Walid A. Atia, David P. Marchessault
-
Publication number: 20230034379Abstract: A device for monitoring a bioreactor is configured for in-situ analysis, e.g., by NIR, without the need for withdrawing a sample into a sample cell or into an ex-situ arrangement. The device can be inserted into a port of the bioreactor and provides a sample detection region defined by an optical element such as a lens and a photodetector. The electrical signal obtained from a photodetector that is part of the device can be directed to an analyzer via a detachable electrical connection.Type: ApplicationFiled: October 13, 2022Publication date: February 2, 2023Applicant: Nirrin Technologies, Inc.Inventors: Bryan A. Hassell, David P. Marchessault, Christopher R. Saulnier, John C. Ho, Walid A. Atia
-
Patent number: 11499903Abstract: A device for monitoring a bioreactor is configured for in-situ analysis, e.g., by NIR, without the need for withdrawing a sample into a sample cell or into an ex-situ arrangement. The device can be inserted into a port of the bioreactor and provides a sample detection region defined by an optical element such as a lens and a photodetector. The electrical signal obtained from a photodetector that is part of the device can be directed to an analyzer via a detachable electrical connection.Type: GrantFiled: September 23, 2020Date of Patent: November 15, 2022Assignee: NIRRIN TECHNOLOGIES, INC.Inventors: Bryan A. Hassell, David P. Marchessault, Christopher R. Saulnier, John C. Ho, Walid A. Atia